Vanguard Capital Management’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.7M Sell
3,967,899
-42,023
-1% -$380K ﹤0.01% 2201
2026
Q2
$40.1M Buy
4,009,922
+1,335,298
+50% +$10.1M ﹤0.01% 2070
2026
Q1
$19.3M Buy
+2,674,624
New +$17.2M ﹤0.01% 2364

Other funds holding SLDB

Vanguard Capital Management's SLDB Position: Q3 2026 in Review

Vanguard Capital Management reduced its Solid Biosciences (SLDB) stake by 1% in Q3 2026, selling an estimated $380K and leaving 3,967,899 shares worth $28.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

Vanguard Capital Management first reported a position in SLDB in Q1 2026 and has held it in 3 quarters since. The position peaked at $40.1M in Q2 2026. 158 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • Vanguard Capital Management held 3,967,899 shares of Solid Biosciences worth $28.7M as of Q3 2026.
  • Vanguard Capital Management sold 42,023 Solid Biosciences shares in Q3 2026, an estimated $380K.
  • Solid Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2201 holding.
  • Vanguard Capital Management first reported a position in Solid Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Solid Biosciences position peaked at $40.1M in Q2 2026.
  • 158 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.